Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine + cytarabine versus cytarabine in older adults with relapsed/refractory AML
2008-001043-19Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clofarabine in acute myeloid leukemia (AML) (2 arms), sponsored by Sanofi. Primary endpoint: overall survival. Started Jul 2008; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on 2008-001043-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001043-19.